PRX-08066

DRUG2 trials

Sponsors

Epix Pharmaceuticals, Inc.

Conditions

COPDChronic Obstructive Pulmonary DiseasePulmonary Hypertension

Phase 2

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

CompletedNCT00345774

Epix Pharmaceuticals, Inc.Chronic Obstructive Pulmonary Disease, Pulmonary Hypertension

Start: 2006-06-30End: 2007-06-30Target: 72Updated: 2008-05-29

An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

TerminatedNCT00677872

Epix Pharmaceuticals, Inc.COPD, Pulmonary Hypertension

Start: 2008-05-31Target: 40Updated: 2009-07-30